tetano
Editor, Senior Moderator
J Virol
. 2024 Apr 3:e0041124.
doi: 10.1128/jvi.00411-24. Online ahead of print. Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3
Filo Silva[SUP] 1 [/SUP], Inês Boal-Carvalho[SUP] 1 [/SUP], Nathalia Williams[SUP] #[/SUP][SUP] 1 [/SUP], Mehdi Chabert[SUP] #[/SUP][SUP] 1 [/SUP], Chengyue Niu[SUP] 1 [/SUP], Dalila Hedhili[SUP] 1 [/SUP], Hélèna Choltus[SUP] 1 [/SUP], Nicolas Liaudet[SUP] 2 [/SUP], Nadia Gaïa[SUP] 3 [/SUP], Wolfram Karenovics[SUP] 4 [/SUP], Patrice Francois[SUP] 1 4 [/SUP], Mirco Schmolke[SUP] 1 5 [/SUP]
Affiliations
Influenza A virus infection activates the NLRP3 inflammasome, a multiprotein signaling complex responsible for the proteolytic activation and release of the proinflammatory cytokine IL-1β from monocytes and macrophages. Some influenza A virus (IAV) strains encode a short 90-amino acid peptide (PB1-F2) on an alternative open reading frame of segment 2, with immunomodulatory activity. We recently demonstrated that contemporary IAV PB1-F2 inhibits the activation of NLRP3, potentially by NEK7-dependent activation. PB1-F2 binds to NLRP3 with its C-terminal 50 amino acids, but the exact binding motif was unknown. On the NLRP3 side, the interface is formed through the leucine-rich-repeat (LRR) domain, potentially in conjunction with the pyrin domain. Here, we took advantage of PB1-F2 sequences from IAV strains with either weak or strong NLRP3 interaction. Sequence comparison and structure prediction using Alphafold2 identified a short four amino acid sequence motif (TQGS) in PB1-F2 that defines NLRP3-LRR binding. Conversion of this motif to that of the non-binding PB1-F2 suffices to lose inhibition of NLRP3 dependent IL-1β release. The TQGS motif further alters the subcellular localization of PB1-F2 and its colocalization with NLRP3 LRR and pyrin domain. Structural predictions suggest the establishment of additional hydrogen bonds between the C-terminus of PB1-F2 and the LRR domain of NLRP3, with two hydrogen bonds connecting to threonine and glutamine of the TQGS motif. Phylogenetic data show that the identified NLRP3 interaction motif in PB1-F2 is widely conserved among recent IAV-infecting humans. Our data explain at a molecular level the specificity of NLRP3 inhibition by influenza A virus.
Importance: Influenza A virus infection is accompanied by a strong inflammatory response and high fever. The human immune system facilitates the swift clearance of the virus with this response. An essential signal protein in the proinflammatory host response is IL-1b. It is released from inflammatory macrophages, and its production and secretion depend on the function of NLRP3. We had previously shown that influenza A virus blocks NLRP3 activation by the expression of a viral inhibitor, PB1-F2. Here, we demonstrate how this short peptide binds to NLRP3 and provide evidence that a four amino acid stretch in PB1-F2 is necessary and sufficient to mediate this binding. Our data identify a new virus-host interface required to block one signaling path of the innate host response against influenza A virus.
Keywords: IL-1beta; NLRP3; PB1-F2; inflammasome; inflammation; influenza; macrophage; protein interactions.
. 2024 Apr 3:e0041124.
doi: 10.1128/jvi.00411-24. Online ahead of print. Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3
Filo Silva[SUP] 1 [/SUP], Inês Boal-Carvalho[SUP] 1 [/SUP], Nathalia Williams[SUP] #[/SUP][SUP] 1 [/SUP], Mehdi Chabert[SUP] #[/SUP][SUP] 1 [/SUP], Chengyue Niu[SUP] 1 [/SUP], Dalila Hedhili[SUP] 1 [/SUP], Hélèna Choltus[SUP] 1 [/SUP], Nicolas Liaudet[SUP] 2 [/SUP], Nadia Gaïa[SUP] 3 [/SUP], Wolfram Karenovics[SUP] 4 [/SUP], Patrice Francois[SUP] 1 4 [/SUP], Mirco Schmolke[SUP] 1 5 [/SUP]
Affiliations
- PMID: 38567952
- DOI: 10.1128/jvi.00411-24
Influenza A virus infection activates the NLRP3 inflammasome, a multiprotein signaling complex responsible for the proteolytic activation and release of the proinflammatory cytokine IL-1β from monocytes and macrophages. Some influenza A virus (IAV) strains encode a short 90-amino acid peptide (PB1-F2) on an alternative open reading frame of segment 2, with immunomodulatory activity. We recently demonstrated that contemporary IAV PB1-F2 inhibits the activation of NLRP3, potentially by NEK7-dependent activation. PB1-F2 binds to NLRP3 with its C-terminal 50 amino acids, but the exact binding motif was unknown. On the NLRP3 side, the interface is formed through the leucine-rich-repeat (LRR) domain, potentially in conjunction with the pyrin domain. Here, we took advantage of PB1-F2 sequences from IAV strains with either weak or strong NLRP3 interaction. Sequence comparison and structure prediction using Alphafold2 identified a short four amino acid sequence motif (TQGS) in PB1-F2 that defines NLRP3-LRR binding. Conversion of this motif to that of the non-binding PB1-F2 suffices to lose inhibition of NLRP3 dependent IL-1β release. The TQGS motif further alters the subcellular localization of PB1-F2 and its colocalization with NLRP3 LRR and pyrin domain. Structural predictions suggest the establishment of additional hydrogen bonds between the C-terminus of PB1-F2 and the LRR domain of NLRP3, with two hydrogen bonds connecting to threonine and glutamine of the TQGS motif. Phylogenetic data show that the identified NLRP3 interaction motif in PB1-F2 is widely conserved among recent IAV-infecting humans. Our data explain at a molecular level the specificity of NLRP3 inhibition by influenza A virus.
Importance: Influenza A virus infection is accompanied by a strong inflammatory response and high fever. The human immune system facilitates the swift clearance of the virus with this response. An essential signal protein in the proinflammatory host response is IL-1b. It is released from inflammatory macrophages, and its production and secretion depend on the function of NLRP3. We had previously shown that influenza A virus blocks NLRP3 activation by the expression of a viral inhibitor, PB1-F2. Here, we demonstrate how this short peptide binds to NLRP3 and provide evidence that a four amino acid stretch in PB1-F2 is necessary and sufficient to mediate this binding. Our data identify a new virus-host interface required to block one signaling path of the innate host response against influenza A virus.
Keywords: IL-1beta; NLRP3; PB1-F2; inflammasome; inflammation; influenza; macrophage; protein interactions.